A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus
- PMID: 15456089
A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus
Abstract
A system of reverse genetics was used to generate influenza A/H1N1 viruses harbouring neuraminidase (NA) mutations previously associated with resistance to NA inhibitors in various viral subtypes. The His274Tyr and Glu119Gln mutants were rescued whereas the Arg292Lys and Glu1l9 --> Gly, Val, Ala or Asp mutants could not be generated. In NA inhibition assays, the His274Tyr mutant was resistant to oseltamivir (430-fold over wild-type) and BCX-1812 (50-fold) but was sensitive to zanamivir. A similar trend was seen when the mutant was evaluated by plaque reduction assay (PRA). The Glu119Gln mutant expressed a low level of resistance to oseltamivir (nine-fold) and zanamivir (fourfold) in NA inhibition assay but was only marginally resistant to oseltamivir (fourfold) in PRA. The replication capacity of both mutants, in particular that of the His274Tyr virus, was impaired when compared with the wild-type virus in vitro.
Similar articles
-
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.Antimicrob Agents Chemother. 2001 Dec;45(12):3403-8. doi: 10.1128/AAC.45.12.3403-3408.2001. Antimicrob Agents Chemother. 2001. PMID: 11709315 Free PMC article.
-
Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.J Antimicrob Chemother. 2006 Oct;58(4):723-32. doi: 10.1093/jac/dkl321. Epub 2006 Aug 5. J Antimicrob Chemother. 2006. PMID: 16891631
-
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.J Virol. 2002 Jun;76(11):5380-6. doi: 10.1128/jvi.76.11.5380-5386.2002. J Virol. 2002. PMID: 11991966 Free PMC article.
-
Treatment of influenza with neuraminidase inhibitors: virological implications.Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1895-7. doi: 10.1098/rstb.2001.1002. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11779389 Free PMC article. Review.
-
[Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].Nihon Rinsho. 2003 Nov;61(11):1975-9. Nihon Rinsho. 2003. PMID: 14619441 Review. Japanese.
Cited by
-
I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y.PLoS One. 2012;7(8):e37095. doi: 10.1371/journal.pone.0037095. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22936969 Free PMC article.
-
Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.Antimicrob Agents Chemother. 2010 Jul;54(7):2819-22. doi: 10.1128/AAC.01681-09. Epub 2010 Apr 19. Antimicrob Agents Chemother. 2010. PMID: 20404128 Free PMC article.
-
A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.PLoS One. 2011;6(7):e22201. doi: 10.1371/journal.pone.0022201. Epub 2011 Jul 20. PLoS One. 2011. PMID: 21799795 Free PMC article.
-
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.PLoS Pathog. 2008 Jul 25;4(7):e1000103. doi: 10.1371/journal.ppat.1000103. PLoS Pathog. 2008. PMID: 18654625 Free PMC article. No abstract available.
-
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.PLoS Pathog. 2014 Apr 3;10(4):e1004065. doi: 10.1371/journal.ppat.1004065. eCollection 2014 Apr. PLoS Pathog. 2014. PMID: 24699865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials